Browse the full directors' dealings record of 振东制药, a listed equity based in France. Shares trade on FR FR, under the oversight of AMF. Market capitalisation: €5.8bn. The latest transaction was disclosed on 26 January 2026 — Purchase. Among the most active insiders: 雷振宏. All data is free.